Ashland Completes Expansion of R&D Facility in Ireland

Ashland recently completed the expansion of its Viatel™ bioresorbable polymer manufacturing site and has relocated research and development from Dublin to the National Science Park, Mullingar, Ireland, the company said in a news release.

The National Science Park in Mullingar houses a number of organizations, including a research center for manufacturing solutions.

“Viatel™ bioresorbable polymers are used to deliver improved treatment solutions for many chronic diseases,” said Seán McMahon, Ph.D., business manager, Viatel™ bioresorbable polymers, Ashland. “These materials are the building blocks in extended-release drug formulations, bioresorbable medical devices, and tissue engineering scaffolds. Relocation of R&D to the Mullingar site is critical for our new product development strategy and our ability to solve complex customer challenges with customized chemistry.”

Ashland Global Holdings Inc. (NYSE: ASH) is a specialty materials company that serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical.